ASH 2017: Atlanta Professor Michael Hallek on MRD Negativity in CLL
This content was current as of the date it was released. In science and medicine, information is constantly changing and may become out-of-date as new data emerge.
Genetic tests can be important tools after an initial cancer diagnosis, helping doctors ensure the absolute best treatment available for a specific patient with a specific kind of cancer.
To follow-up on the Facebook chat I had at the ASH meeting last December, I will be hosting another Facebook Live Interactive workshop on the importance of genetic testing before treatment in CLL. I will be broadcasting from the 17th International Workshop on Chronic Lymphocytic Leukemia (iwCLL) being held in New York City.
Join me, ask questions and cheer me along at 3:45 PM ET on this Saturday, May 13th.
Your link to join is https://www.facebook.com/CLLsociety/
I look forward to your questions and to hearing your thoughts.
Stay strong.
We are all in this together.
Brian Koffman, MD 5-12-17
Related posts